Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2007, Pages 564-571

  Davis, J L ^a   Foster, D M ^a   Papich, M G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TOLERABILITY; GLUTEUS MAXIMUS MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION SITE SWELLING; INTERSTITIAL FLUID; NONHUMAN; PLASMA PROTEIN BINDING; PLEURA CAVITY; PRIORITY JOURNAL; ULTRAFILTRATION;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CATTLE; CIPROFLOXACIN; FLUOROQUINOLONES; INJECTIONS, SUBCUTANEOUS; TISSUE DISTRIBUTION;

EID: 35848941915     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00914.x     Document Type: Article

References (43)

1. AliAbadi, F.S. Lees, P. (2000) Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimization. International Journal of Antimicrobial Agents, 14, 307 313.
2. Aliabadi, F.S. Lees, P. (2002) Pharmacokinetics and pharmacokinetics/ pharmacodynamic integration of marbofloxacin in calf serum, exudates and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25, 161 174.
3. Ambrose, P.G. Grasela, D.M. (2000) The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease, 38, 151 157.
4. Andes, D. Craig, W.A. (2002) Animal model pharmacokinetics and pharmacodynamics: a critical review. International Journal of Antimicrobial Agents, 19, 261 268.
5. Asuquo, A.E. Piddock, L.J.V. (1993) Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 31, 865 880.
6. Bengtsson, B., Luthman, J. Jacobsson, S.O. (1986) Penetration of oxytetracycline into tissue-cages in calves. Journal of Veterinary Pharmacology and Therapeutics, 9, 71 80.
7. Bengtsson, B., Luthman, J., Jacobsson, S.O. Ekman, S. (1991) Distribution of oxytetracycline to tissue cages and granuloma pouches in calves and effect of acute inflammation on distribution to tissue cages. Journal of Veterinary Pharmacology and Therapeutics, 14, 385 394.
8. Bermingham, E.C. Papich, M.G. (2002) Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. American Journal of Veterinary Research, 63, 1012 1017.
9. Bermingham, E.C., Papich, M.G. Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706 709.
10. Bidgood, T. Papich, M.G. (2002) Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs. American Journal of Veterinary Research, 63, 1622 1628.
11. Bidgood, T. Papich, M.G. (2003) Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. American Journal of Veterinary Research, 64, 1040 1046.
12. Bidgood, T. Papich, M.G. (2005) Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 329 341.
13. Bregante, M.A., DeJong, A., Aramayona, J.J., Garcia, M.A., Solans, C. Rueda, S. (2000) Protein binding of fluoroquinolones applied to livestock and companion animals [abstract B16]. In Abstracts of the 8th International Congress. Eds Stefan, S. McKellar, Q.A. European Academy of Veterinary Pharmacology and Therapeutics, Tel Aviv, Jerusalem, Israel.
14. Cars, O. (1991) Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scandinavian Journal of Infectious Disease, 74 (Suppl 23 33.
15. Cars, O. Ogren, S. (1985) Antibiotic tissue concentrations: methodological aspects and interpretation of results. Scandinavian Journal of Infectious Disease, 44 (Suppl 7 15.
16. Clarke, C.R., Short, C.R., Boourne, D.W.A. Usenik, E.A. (1989a) Subcutaneous implanted tissue chambers: a pharmacokinetic study. Journal of Veterinary Pharmacology and Therapeutics, 12, 312 321.
17. Clarke, C.R., Short, C.R., Corstvet, R.E. Nobles, D. (1989b) Effect of Pasteurella haemolytica infection on distribution of sulfadiazine and trimethoprim into tissue chambers implanted subcutaneously in cattle. American Journal of Veterinary Research, 50, 1551 1555.
18. Craig, W.A. (1998) Choosing an antibiotic on the basis of pharmacodynamics. Ear Nose and Throat Journal, 77 (Suppl. 6 7 11.
19. Davis, J.L., Salmon, J.H. Papich, M.G. (2005a) Pharmacokinetics and tissue distribution of itraconazole after oral and intravenous administration to horses. American Journal of Veterinary Research, 66, 1694 1701.
20. Davis, J.L., Salmon, J.H. Papich, M.G. (2005b) Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and iv administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 425 431.
21. Drusano, G.L., Johnson, D.E., Rosen, M. Standiford, H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483 490.
22. FDA-CDER (1997) Guidance for Industry - Evaluating Clinical Studies of Antimicrobial in the Division of Anti-infective Drug Products. FDA, Rockville, MD, USA.
23. Greko, C., Bengtsson, B., Franklin, A., Jacobsson, S.O., Wiese, B. Luthman, J. (2002) Efficacy of trimethoprim-sulfadoxine against Escherichia coli in a tissue cage model in calves. Journal of Veterinary Pharmacology and Therapeutics, 25, 413 423.
24. Halstead, S.L., Walker, R.D., Baker, J.C., Holland, R.E., Stein, G.E. Hauptman, J.G. (1992) Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves. Canadian Journal of Veterinary Research, 56, 269 274.
25. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. Schentag, J.J. (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Clinical Pharmacokinetics, 28, 143 160.
26. Kaartinen, L., Salonene, M., Alli, L. Pyorala, S. (1995) Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 357 362.
27. Linhares, M.C. Kissinger, P.T. (1993) Pharmacokinetic monitoring in subcutaneous tissue using in vivo capillary ultrafiltration probes. Pharmaceutical Research, 10, 598 602.
28. Liu, P., Müller, M. Derendorf, H. (2002) Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents, 19, 285 290.
29. Lode, H., Borner, K. Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Diseases, 27, 33 39.
30. McKellar, Q., Gibson, I., Monteiro, A. Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudates, bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988 1992.
31. McKellar, Q.A., Sanchez Bruni, S.F. Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503 514.
32. Muller, M., Brunner, M., Schmid, R., Putz, E.M., Schmiedberger, A., Wallner, I. Eichler, H.G. (1998) Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans. Life Sciences, 62, 227 234.
33. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L. Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrobial Agents and Chemotherapy, 35, 1947 1952.
34. Papich, M.G., Van Camp, S.D., Cole, J.A. Whitacre, M.D. (2002) Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. Journal of Veterinary Pharmacology and Therapeutics, 25, 343 350.
35. Prescott, J.F. Yielding, K.M. (1990) In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195 197.
36. Rantala, M., Kaartinen, L., Valimaki, E., Stryrman, M., Hiekkaranta, M., Niemi, A., Saari, L. Pyorala, S. (2002) Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Therapeutics, 25, 251 258.
37. Shah, V.P., Midha, K.K., Dighe, S., McGilveray, I.J., Skelly, J.P., Yacobi, A., Layloff, T., Viswanathan, C.T., Cook, C.E., McDowall, R.D., Pittman, K.A. Spector, S. (1991) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. European Journal of Drug Metabolism and Pharmacokinetics, 16, 249 255.
38. Tejedor, M.T., Martin, J.L., Navia, M., Freixes, J. Vila, J. (2003) Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Veterinary Microbiology, 94, 295 301.
39. TerHune, T.N., Skogerboe, T.L., Shostrom, V.K. Weigel, D.J. (2005) Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica. American Journal of Veterinary Research, 66, 342 349.
40. United States Pharmacopeia (USP-NF) (2007) USP28-NF23. General Chapter on Chromatographic Methods (621), p. 2384. USP, Rockville, MD.
41. Wright, D.H., Brown, G.H., Peterson, M.L. Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669 683.
42. Zlotos, G., Oehlmann, M., Nickel, P. Holzgrabe, U. (1998a) Determination of protein binding of gyrase inhibitors by means of continuous ultrafiltration. Journal of Pharmaceutical and Biomedical Analysis, 18, 847 858.
43. Zlotos, G., Bucker, A., Kinzig-Schippers, M., Sorgel, F. Holzgrabe, U. (1998b) Plasma protein binding of gyrase inhibitors. Journal of Pharmaceutical Science, 87, 215 220.